CUTIA-B (02487) has released its interim results for the six months ended June 30, 2026, showing a net loss attributable to shareholders of RMB 180 million, a reduction of 24.64% compared to the same period last year.

The group recorded revenue of RMB 62.713 million for the period, a year-on-year decline of 5.4%, while the loss per share stood at RMB 0.50.

In a strategic move to accelerate the commercialization of CU-10201 and CU-40102, as well as to prepare for the market launch of CU-30101, the company has decided to terminate certain distribution and agency agreements related to hair disease and daily skincare products. This decision aligns with the group's focus on high-margin product development.

Revenue decreased by 5.4% to approximately RMB 62.7 million for the six months ended June 30, 2026, from about RMB 66.3 million in the corresponding period of 2025. The decline was primarily attributed to the one-off impact from the termination of these distribution and agency partnerships.